Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2017

01-02-2017

Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism: a case control study

Authors: Jason Suh, Amishi Desai, Anish Desai, Josephine Dela Cruz, Anusiyanthan Mariampillai, Alexander Hindenburg

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2017

Login to get access

Abstract

Venous thromboembolism (VTE) remains the number one preventable cause of hospital acquired mortality and morbidity. Each year, more than 12 million patients are at risk for VTE. The delivery of appropriate and timely VTE prophylaxis is still suboptimal in many healthcare institutions and can lead to increased readmissions, morbidity, as well as costs. To clarify this issue further, we performed a retrospective case control study at our institution to determine if poor adherence to the VTE prophylaxis guidelines could lead to an increase in VTE events. This was a retrospective case control study conducted at Winthrop-University Hospital from January 2007 to December 2011. Exclusion criteria were age < 18 and concurrent use of anticoagulant agents. Out of 322 cases of hospital acquired VTE or readmission with VTE within 30 days of discharge, 289 cases were selected for final analysis and paired with age and sex matched controls. Patients with a hospital acquired VTE or a readmission for VTE within 30 days of discharge had a significantly reduced rate of VTE prophylaxis when compared to the control group (54.0 vs. 79.2 %, p < 0.0001). The VTE risk assessment rate was also lower in the VTE group (77.2 vs. 85.5 %, p = 0.035). No difference was noted in the time to prophylaxis administration between the two groups (34.8 vs. 33.1 h, p = 0.34). Lastly, sequential compression device (SCD) documentation rate was not different: 68/116 (58.6 %) vs. 44/87 (50.6 %), p = 0.32, between the two arms. Low adherence to the American College of Chest Physician (ACCP) guidelines for VTE prophylaxis correlated with an increase in hospital acquired VTE. The decreased adherence may be linked to a lower VTE risk assessment rate, and other barriers including incorrect identification of contraindications to pharmacologic prophylaxis, and poor documentation of mechanical prophylaxis. There was no difference in SCD documentation rate and timeliness to administration of initial thromboprophylaxis between the two groups. Future studies are needed to reassess adherence and documentation rates after system-wide improvements.
Literature
1.
go back to reference Heit JA, Melton LJ 3rd, Lohse CM et al (2001) Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc 76:1102–1110CrossRefPubMed Heit JA, Melton LJ 3rd, Lohse CM et al (2001) Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc 76:1102–1110CrossRefPubMed
2.
go back to reference Anderson FA Jr, Zayaruzny M, Heit JA et al (2007) Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 82:777–782CrossRefPubMed Anderson FA Jr, Zayaruzny M, Heit JA et al (2007) Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 82:777–782CrossRefPubMed
3.
go back to reference Ruppert A, Steinle, Lees M (2011) Economic burden of venous thromboembolism: a systematic review. J Med Econ 14:65–74CrossRefPubMed Ruppert A, Steinle, Lees M (2011) Economic burden of venous thromboembolism: a systematic review. J Med Econ 14:65–74CrossRefPubMed
4.
go back to reference MacDougall DA, Feliu AL, Boccuzzi SJ et al (2006) Econonimc burden of deep vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm 63(20 Suppl 6):S5–S15CrossRefPubMed MacDougall DA, Feliu AL, Boccuzzi SJ et al (2006) Econonimc burden of deep vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm 63(20 Suppl 6):S5–S15CrossRefPubMed
5.
go back to reference Guanella R, Ducruet T, Johri M et al (2011) Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost 9:2397–2405CrossRefPubMed Guanella R, Ducruet T, Johri M et al (2011) Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost 9:2397–2405CrossRefPubMed
6.
go back to reference Guyatt GH, Akl EL, Crowther M et al (2012) Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST 141(2 Suppl):7S–47SCrossRefPubMedPubMedCentral Guyatt GH, Akl EL, Crowther M et al (2012) Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST 141(2 Suppl):7S–47SCrossRefPubMedPubMedCentral
7.
go back to reference Languasco A, Galante M, Marín J et al (2011) Adherence to local guidelines for venous thromboprophylaxis: a cross-sectional study of medical inpatients in Argentina. Thromb J 15(9):18CrossRef Languasco A, Galante M, Marín J et al (2011) Adherence to local guidelines for venous thromboprophylaxis: a cross-sectional study of medical inpatients in Argentina. Thromb J 15(9):18CrossRef
8.
go back to reference Kahn SR, Panju A, Geerts W, CURVE study investigators (2007) Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 119(2):145–155CrossRefPubMed Kahn SR, Panju A, Geerts W, CURVE study investigators (2007) Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 119(2):145–155CrossRefPubMed
9.
go back to reference Tapson VF, Decousus H, Pini M et al (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. CHEST 132:936–945CrossRefPubMed Tapson VF, Decousus H, Pini M et al (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. CHEST 132:936–945CrossRefPubMed
10.
go back to reference Cohen AT, Victor FT, Jean-Francois B et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. The Lancet 371:387–394CrossRef Cohen AT, Victor FT, Jean-Francois B et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. The Lancet 371:387–394CrossRef
11.
go back to reference Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107:I9–I16CrossRefPubMed Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107:I9–I16CrossRefPubMed
12.
go back to reference Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6_suppl):381S–453SCrossRefPubMed Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6_suppl):381S–453SCrossRefPubMed
13.
go back to reference Kakkar AK, Cimminiello C, Goldhaber SZ, LIFENOX Investigators (2011) Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med 365(26):2463–2472CrossRefPubMed Kakkar AK, Cimminiello C, Goldhaber SZ, LIFENOX Investigators (2011) Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med 365(26):2463–2472CrossRefPubMed
14.
go back to reference Schleyer AM, Schreuder AB, Jarman KM et al (2011) Adherence to guideline-directed venous thromboembolism prophylaxis among medical and surgical inpatients at 33 academic medical centers in the United States. Am J Med Qual 26(3):174–180CrossRefPubMed Schleyer AM, Schreuder AB, Jarman KM et al (2011) Adherence to guideline-directed venous thromboembolism prophylaxis among medical and surgical inpatients at 33 academic medical centers in the United States. Am J Med Qual 26(3):174–180CrossRefPubMed
15.
go back to reference Cook D, Tkaczyk A, Lutz K et al (2009) Thromboprophylaxis for hospitalized medical patients: a multicenter qualitative study. J Hosp Med 4(5):269–275CrossRefPubMed Cook D, Tkaczyk A, Lutz K et al (2009) Thromboprophylaxis for hospitalized medical patients: a multicenter qualitative study. J Hosp Med 4(5):269–275CrossRefPubMed
16.
go back to reference Daniel D, Maund C, Butler K (2010) Community hospital participation in a pilot project for venous thromboembolism quality measures: learning, collaboration, and early improvement. Jt Comm J Qual Patient Saf 36(7):301–309CrossRefPubMed Daniel D, Maund C, Butler K (2010) Community hospital participation in a pilot project for venous thromboembolism quality measures: learning, collaboration, and early improvement. Jt Comm J Qual Patient Saf 36(7):301–309CrossRefPubMed
17.
go back to reference Piazza G, Goldhaber SZ (2009) Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond. Circulation 120(12):1133–1137CrossRefPubMedPubMedCentral Piazza G, Goldhaber SZ (2009) Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond. Circulation 120(12):1133–1137CrossRefPubMedPubMedCentral
18.
go back to reference Bratzler DW, Hunt DR (2006) The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 43:322–330CrossRefPubMed Bratzler DW, Hunt DR (2006) The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 43:322–330CrossRefPubMed
19.
go back to reference Kucher N, Koo S, Quiroz R et al (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352(10):969–977CrossRefPubMed Kucher N, Koo S, Quiroz R et al (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352(10):969–977CrossRefPubMed
20.
go back to reference Fiumara K, Piovella C, Hurwitz S et al (2010) Multi-screen electronic alerts to augment venous thromboembolism prophylaxis. Thromb Haemost 103(2):312–317CrossRefPubMed Fiumara K, Piovella C, Hurwitz S et al (2010) Multi-screen electronic alerts to augment venous thromboembolism prophylaxis. Thromb Haemost 103(2):312–317CrossRefPubMed
Metadata
Title
Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism: a case control study
Authors
Jason Suh
Amishi Desai
Anish Desai
Josephine Dela Cruz
Anusiyanthan Mariampillai
Alexander Hindenburg
Publication date
01-02-2017
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2017
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-016-1432-6

Other articles of this Issue 2/2017

Journal of Thrombosis and Thrombolysis 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.